ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

Gilead to buy YM BioSciences for about $465 million

December 12, 2012 11:06 am by | 0 Comments

(Reuters) - Gilead Sciences Inc will buy Canada's YM BioSciences Inc for about $465 million to gain access to its blood and immune cell disorder drugs.

Gilead said it will pay $2.95 per YM share.

YM shares closed at C$1.66 on Tuesday on the Toronto Stock Exchange.

(Reporting by Adithya Venkatesan and Shounak Dasgupta in Bangalore; Editing by Roshni Menon)

Advertisement

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
0 comments

Stay Up To Date

Recent Comments

Research Center

Jobs Board

Next Story
Report: Ohioans smoke more, exercise less
Close